Naboso

Sensory products to optimise movement

Naboso

Sensory products to optimise movement

Chandler, AZ
Consumer Products
Health Tech
Naboso has developed a proprietary textured material that has proven to have an instantaneous effect on enhancing movement. Using their unique material, they’ve manufactured sensory insoles, mats, and flooring — all of which activate the nervous system through stimulation of the feet. While continuing to innovate within the health and wellness space, Naboso continues to positively impact the lives of those living with chronic neurological conditions along with elite level athletes and everyone in-between.

$331,325

raised
449
Investors
$9.88M
Valuation
$0.81
Price per Share
$149.04
Min. Investment
Common
Shares Offered
Equity
Offering Type
$1.07M
Offering Max
Reg CF
Offering

$331,325

raised
449
Investors
$9.88M
Valuation
$0.81
Price per Share
$149.04
Min. Investment
Common
Shares Offered
Equity
Offering Type
$1.07M
Offering Max
Reg CF
Offering

Rewards

Get rewarded for investing more into Naboso:

$149+
Investment
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.
$250+
Investment
Tier 1 perk
($250 + Pair of Duo Insoles)
$500+
Investment
Tier 2 perk
($500 + Pair of Duo Insoles + Neuro Ball)
$1,000+
Investment
Tier 3 perk
($1000 + Pair of Duo Insoles + NeuroBall + 25% off sitewide 2x a year)
$5,000+
Investment
Tier 4 perk
($5,000+ Pair of Duo Insoles + NeuroBall + 30% off sitewide 2x a year)
$10,000+
Investment
Tier 5 perk
($10,000+ Pair of Duo Insoles + NeuroBall + 30% off sitewide 2x a year + 5% bonus shares)
$25,000+
Investment
Tier 6 perk
($25,000+ Pair of Duo Insoles + NeuroBall + 30% off sitewide 2x a year + 10% bonus shares)
$50,000+
Investment
Tier 7 perk
($50,000+ Pair of Duo Insoles + NeuroBall + 30% off sitewide 2x a year + 15% bonus shares)

Reasons to Invest

68% revenue growth over the past year during a global pandemic. Naboso has global distribution in 9 countries, and oversees direct-to-consumer sales throughout the U.S. and Europe, with continued product innovations and partnership licensing.
Innovative textured product lines have proven to increase balance, gait, strength, stability, and posture with applications in medical, wellness and performance.
Founded by a renowned podiatrist and global leader in barefoot training and rehabilitation with many media appearances including ​The Today Show​, ​The Oprah Winfrey Show​, and ​The Doctors​.

Overview


Innovative products backed by texture science that change the way people move, instantly

Naboso has developed a proprietary textured material that instantly strengthens the neurological connection between one’s brain and their feet. This sensory material serves as the foundation for a variety of products that optimize movement from the ground up, all while promoting maximum body awareness and muscle recruitment. 

Whether you are an elite athlete, someone living with a chronic neurological condition like neuropathy, or an individual working on their feet all day long, Naboso’s products are here to keep you connected to your foundation. 

The Problem


The footwear and insole markets are ruining more than just feet

Feet were never meant to be crammed into narrow shoes, smashed down into cushioned soles and disconnected from the sensory stimulation of each step we take. Inhibiting toe spread, along with the reduction of foot sensation over time, can lead to foot pain, deformities, movement disorders, and postural and muscular imbalances.


Meanwhile, the insole market continues to focus on artificial arch support and cushion, both of which are often short-term solutions that lead to greater muscular compensations and a disconnect from our feet. As a result, we are improperly positioning our feet and overlooking one of the most important factors for foot strength and body coordination: sensory stimulation.  

With sensory stimulation as the foundation to movement, current footwear and insoles actually contribute to a sensory disconnect between the body and the ground we walk on. This sensory disconnect has been shown to contribute to atrophy of foot muscles, poor posture and even increases fall risk. 

The Solution


An instant brain and body connection that starts at your feet

It's time to bring the power of barefoot back into footwear and insoles. With Naboso's proprietary textured product line, feet are now able to stay stimulated regardless of the footwear or environment we are in. As the only sensory product line on the market, Naboso is helping to awaken the areas of the brain that allow for an instantaneous increase in neuro-muscular control. By increasing the neurological connection between the brain and the body’s foundation, Naboso enhances movement and body control.

Why Invest


Naboso has created an entirely new category that is changing lives through movement

Founded by passion for the health and wellness of others, Naboso is unlike any other insole or mat on the market. Led by a Functional Podiatrist with a deep understanding of texture science and the benefits of foot stimulation, Naboso’s approach is simple: Stimulate the feet. Activate the brain. Utilize more of the body. 

Customers from NASA, FYZICAL Balance Centers, and the MS Mandell Center are experiencing the powerful effects of foot stimulation and the Naboso textured product line. Patients at these centers are experiencing the power of sensory input and agree that Movement is life, and life is sensory.

The Market


Accessing several industries on the rise with the use of texture science

There are over 20 million adults in the US living with neuropathy or the inability to feel their feet (source), 43 million Americans who report experiencing foot pain every year (source), and approximately 65% of employees report prolonged standing at work causing over $2.6 billion in associated ergonomic health care costs (source). 

The global insole market is on its way to reaching $3.68 billion (source), with diabetes and the aging population as the biggest drivers to this market growth.

In addition, the global footwear industry is worth $365 billion (source); all of which Naboso fits into. 

TRACTION LED BY PROVEN RESULTS 


Naboso makes a difference

A 2020 Stanley Black & Decker pilot study showed that standing employees who wore Naboso insoles for six weeks experienced a 93% decrease in reported foot pain, 78% decrease in reported back pain, and 87% decrease in reported musculoskeletal fatigue. This was all associated with a reported 77% increase in productivity. 

In the past year Naboso had 68% growth in revenue, as well as expansion into the European and Asian markets, and the launch of two new product innovations. Naboso has global distribution in nine regions and sells direct to consumers through a newly designed e-commerce platform in the U.S., across Europe, and, starting February 2021, in Australia. 


The power of Naboso is not only in their textured product line but also in the licensing opportunities of their proprietary material. With 5 license agreements including Xero Shoes, Power Plate, True Form Runner, BodiTrak and RAD Roller, the impact of Naboso is outreaching their network within medical, wellness and performance.

WHAT NABOSO DOES 


Increasing strength, balance, posture, and gait starting in the sole

The brain can only control what it’s connected to. Using the Naboso product line to stimulate the bottom of the feet keeps your body and brain connected. An increase in foot and body awareness allows for optimal movement and puts you in control of your full potential. Optimized movement is for everyone, and so is Naboso.

The Business Model


Selling direct to consumer and business to business

The Naboso product portfolio is comprised of 5 insoles, 4 mats, a newly launched release ball, floor paneling, and texture sheets that are currently sold to orthotic labs. In addition to Naboso manufactured products, there are also five licensed product collaborations with companies such as Xero Shoes, TrueForm Runner, RAD Roller, Boditrak, and Power Plate. 

DTC accounts for 60% of sales revenue. Naboso’s newly designed website and e-commerce platform is increasing sales in the US and Europe, and products are also available for purchase on Amazon in the US, Canada, and Europe. Selling direct to consumer allows for a 94% profit margin on insoles, and 69% for mats.

BTB accounts for 40% of sales revenue. Naboso products are sold to retailers, resellers, and distributors across North America, Europe, Asia, and Australia. Selling business to business allows for an 88% profit margin on insoles, and 55% on mats. 

The Vision


Change lives with movement

Naboso is redefining how the world perceives the foot, and will continue to educate the benefits of sensory science and texture stimulation. Naboso has one goal: enable people to move in their highest capacity for as long as possible, during any life stage. 

Whether you are treating an ailment, going through recovery, living with an acute or chronic neurological disorder, on your feet for extended periods of time, hitting your next training session, or preparing for a big game, movement is life, and Naboso is there every step of the way.

OUR LEADERSHIP


Podiatrist. Entrepreneur. Founder.

Founder of Naboso, Dr. Emily Splichal has been traveling the world to share her unique approach to human movement, foot function, and barefoot science. Having taught 25,000 professionals in 40 countries, Dr. Splichal has quickly become a global leader in barefoot training and rehabilitation.

In addition to industry leadership, Dr. Splichal has a strong media presence and has appeared on The Today Show, The Oprah Winfrey Show, The Doctors, HSN, The New Yorker, The L A Times, and Shape Magazine. 

In the Press

CIVILIAN MAGAZINE
January 1, 2017

Healthy Designed for Home

Athletics Weekly
January 1, 2017

A Helping Hand

Digital Trends
January 1, 2017

Insoles claim to fight Parkinson’s symptoms by stimulating nerves in your feet

Athletic Business

Naboso Technology and TrueForm Runner Launch the First and Only Proprioceptive Treadmill for Rehabilitation and Performance

Multiple Sclerosis New Today

New Products Intended to Stimulate Feet of MS Patients

Offering Summary


Company

:

Naboso Technology, Inc.

Corporate Address

:

6825 W Galveston Street Suite 9 , Chandler, AZ 85226

Offering Minimum

:

$9,999.45

Offering Maximum

:

$1,069,998.66

Minimum Investment Amount

(per investor)

:

$149.04











Terms


Offering Type

:

Equity

Security Name

:

Common Stock

Minimum Number of Shares Offered

:

12,345

Maximum Number of Shares Offered

:

1,320,986

Price per Share

:

$0.81

Pre-Money Valuation

:

$9,882,000.00











COVID Relief

This offering is being conducted on an expedited basis due to circumstances relating to COVID-19 and pursuant to the SEC’s temporary regulatory COVID-19 relief set out in Regulation Crowdfunding §227.201(z).

Expedited closing sooner than 21 days

Further, in reliance on Regulation Crowdfunding §227.303(g)(2) A funding portal that is an intermediary in a transaction involving the offer or sale of securities initiated between May 4, 2020, and February 28, 2021, in reliance on section 4(a)(6) of the Securities Act (15 U.S.C. 77d(a)(6)) by an issuer that is conducting an offering on an expedited basis due to circumstances relating to COVID-19 shall not be required to comply with the requirement in paragraph (e)(3)(i) of this section that a funding portal shall not direct transmission of funds earlier than 21 days after the date on which the intermediary makes publicly available on its platform the information required to be provided by the issuer under §§227.201 and 227.203(a).

*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below.

Company Perks*

Early Bird (first 72 hours)

Friends and Family - First 24 hours | 15% bonus shares

Super Early Bird - Next 24 hours | 10% bonus

Early Bird Bonus - Next 24 hours | 5% bonus shares

Volume

Tier 1 perk - ($250 + Pair of Duo Insoles)

Tier 2 perk - ($500 + Pair of Duo Insoles + Neuro Ball) 

Tier 3 perk - ($1000 + Pair of Duo Insoles + NeuroBall + 25% off sitewide 2x a year)

Tier 4 perk - ($5,000+ Pair of Duo Insoles + NeuroBall + 30% off sitewide 2x a year)

Tier 5 perk - ($10,000+ Pair of Duo Insoles + NeuroBall + 30% off sitewide 2x a year + 5% bonus shares)

Tier 6 perk - ($25,000+ Pair of Duo Insoles + NeuroBall + 30% off sitewide 2x a year + 10% bonus shares)

Tier 7 perk - ($50,000+ Pair of Duo Insoles + NeuroBall + 30% off sitewide 2x a year + 15% bonus shares)

*All perks that occur when the offering is complete must be added right below the company perks.

The 10% StartEngine Owners' Bonus

Naboso will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of common stock at $0.81 / share, you will receive 110 shares of common stock, meaning you'll own 110 shares for $81. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investors' eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.

Investors will only receive a single bonus, which will be the highest bonus rate they are eligible for.

The Company will not incur any irregular use of proceeds.


Show More
Most recent fiscal year-end:
Prior fiscal year-end:
Total Assets
$584,336.00 USD
$185,870.00 USD
Cash And Cash Equivalents
$62,014.00 USD
$33,799.00 USD
Accounts Receivable
$10,178.00 USD
$8,955.00 USD
Short Term Debt
$333,729.00 USD
$46,251.00 USD
Long Term Debt
$200,916.00 USD
$51,008.00 USD
Revenues And Sales
$773,882.00 USD
$461,172.00 USD
Costs Of Goods Sold
$241,485.00 USD
$125,562.00 USD
Taxes Paid
$0.00 USD
$0.00 USD
Net Income
-$44,920.00 USD
-$9,949.00 USD

Risks

A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.


Updates

Naboso Success Story - Meet Myrna, Diagnosis MS

23 hours ago

Hello Investors and Followers of Naboso. 

We wanted to share with all of you a success story that came out of our recent Neuropathy Pilot Study

This is the story of Myrna, a woman who was diagnosed with MS in 2013. 

***

For years Myrna worked as a massage therapist before her 2013 diagnosis with MS.  Due to her background in massage and exercise, she maintained a fairly positive attitude despite her diagnosis. Stating that as soon as she heard she had MS, her initial reaction was "let's get after it in the most holistic way possible"

Nothing had stopped Myrna from doing what she enjoyed, it just took her a little longer. 

But then her foot began to get weaker and gait became less stable. In December 2019 her lesions were spreading throughout her brain and spinal column. The Neurologist said she would be in a wheelchair by 2020.

March 2020 lockdown allows Myrna time to learn anything she could do to improve herself. From webinars and ZOOM yoga to lots of qigong and meditation....then Naboso was doing a study.    

Myrna had actually tried the Naboso Insoles briefly in the past but decided to be part of the Naboso Neuropathy Pilot anyways. The response to the Neuro Insoles is below in Myrna’s own words. 

“I received the [Neuro] insoles on Sunday 2/28 and wore them in all shoes, all day, every day. After 5 days I experienced the sensation of wanting to jog to the mailbox. 

I couldn't get the first step but the urge was strong. 

7 days into wearing [the Neuro Insoles] I could jog 3 to 5 steps there and 2 back. 

Day 8 and 9, I could jog a few steps, stop and then restart.   

On the 10th day, I was in a car dealership and I was overcome with the urge and just started running around.  My daughter took a video.

On day 11, I ran a mile nonstop

On day 12, I ran 2 miles non-stop.  No stumbling no tripping

It's been 17 days and I jog every day with no fear of falling, My balance is so great I brought lunch to my daughter and climbed 2 flights of stairs with lunch and drinks in both hands.  It was the same daughter who filmed the jog and she couldn't believe her eyes...And I loved her smile of joy! 

The carry-over effect to barefoot is noticeable. 

The neuropathy is diminishing, drop foot recovering, and I couldn't be in a better place emotionally, and mentally.”

***

We are so grateful for Myrna to share her success story with all of us and wanted this to be a story of inspiration.    

We also wanted to share the positive effect that all of your investments have made so far on so many people's lives.    Myrna is just one of the many stories we hear every week at Naboso. 

The simple but powerful impact movement has on the emotional and mental well being of these individuals is why we do what we do at Naboso. 

I thank you all again, and remember, movement is life and life is sensory! 

Dr Splichal, CEO 


"I can feel my feet again!" | Naboso Neuropathy Pilot Results

15 days ago

Greetings to all who have invested so far in Naboso and to those following our growth. 

We have just completed our 6 weeks Naboso Neuropathy Pilot and are excited to share the results with you.  But before we do, I want to quickly position why this pilot is so important to Naboso and patient around the world. 

***

With over 20 million adults in the United States living with decreased foot awareness and the inability to feel the ground, the diagnosis of neuropathy can be life-changing.

Chronic neurological conditions, such as neuropathy, may not be life-threatening but this does not mean they do not impact lives in a great way. 

The simple act of walking is greatly affected by the inability to feel the ground, and contributes to a $50 billion dollar annual cost of fall-related healthcare costs.  

At Naboso, our simple, but powerful sensory insoles are helping those living with neuropathy reconnect to their feet.  

***  

So let's get into the results of our pilot!

Of the 40 participants, all with diagnosed peripheral neuropathy, 87% of subjects noticed a positive increase in their foot sensation and foot awareness.

“Until I tried the insoles, I had no idea that my whole foot wasn't feeling the ground/floor when I walked. It was an eye-opener. After wearing the insole, I have more confidence in my steps, even when I not wearing the insoles. I think my balance has improved. Also, I can walk barefoot for a little bit of time with less pain. I am very pleased with my results.”  - Pilot participant 

74% of subjects noticed a positive change in their balance and stability when walking

“My pedometer on my phone tracks differential in my steps, like how different each stride is - I don't know how accurate it is, but it always used to be 20-30% variance, and now it is typically 0-5% meaning strides are equal, no limping or anything!” - Pilot participant 

97% of subjects would recommend Naboso Insoles to a friend or neighbor who also has neuropathy.

“As an MS patient with foot drop, walking is what I desire to do most of all. I do believe the insoles have brought to life parts of my feet that weren't cooperating. I think I take more confident steps due to being more foot aware, using the whole foot. I have been walking more and building strength.” – Pilot participant 

***

We understand that this initial pilot was built around subjective feedback by subjects but this is still important data in understanding the efficacy of Naboso with neurological conditions.    

Your investment will be supporting our future research in better understanding the efficacy of our products for those with neurological conditions such as neuropathy.   

I cannot thank you all enough for your continued support of Naboso and for your current investment. 

Kindly 

Dr Splichal, CEO 


Full article with neuropathy pilot results


Q1 2021 Revenue Report - 2.85X growth achieved!

28 days ago

Thank you to all who have continued to follow Naboso Technology and our Crowd Equity Campaign!    

As we wrap up Q1 of 2021 we are super excited to share that we have achieved a 2.85x growth compared to Q1 2020. 

This strong start into 2021 puts us on a trajectory to exceed our earlier projections and we are hoping to hit $2 million in revenue this year! 

This is important for all of our investors and those who are considering investing in Naboso as we believe we will be profitable once we hit $1.2 million in revenue. 

We'd love for you to join us on this journey and become a part of the Naboso Family by investing today. 

Stay tuned for further updates. 

Dr Splichal, CEO Naboso 


Naboso Launches New Distribution Partnership in Australia

about 1 month ago

To all who are invested in and following Naboso Technology, we are excited to announce the launch of out new distribution partnership with Australian footwear distributor Stepping Out Footwear, Pty, Ltd.  

Stepping Out Footwear will be handling all of ourD2C website fulfillment offering our Australian customers faster shipping times and better rates.  In addition, they will be selling our products on their own site and overseeing B2B outreach and wholesaler relations.  

This partnership with Stepping Out Footwear will allow us to streamline our Australian D2C fulfillment process and expand our outreach within the reseller and wholesales markets.  

Our decision to expand D2C outreach in Australia is part of our larger global growth strategy for Naboso.   

You may find the full press release below.

Thank you all so much 

Dr Splichal 

https://www.issuewire.com/naboso-technology-launches-new-distribution-partnership-in-australia-1696601736549131


Naboso Brings (Foot) Awareness to the Golfer | Naboso Golf Pilot Results

about 1 month ago

Preparation for the swing, weight distribution into the feet...few sports compare to golf in the subtleties in a movement pattern. Due to the small movement shifts during a golf swing perfecting this pattern can be hard to achieve. High foot and body awareness are required to attain peak performance.   

At Naboso Technology we appreciate this concept of foot and body awareness, and have built it into our sole (pun intended) purpose. To demonstrate the efficacy of our products for the golf market we conducted a pilot study. 

Naboso Golf PIlot Study 

We had 50 golfers of varying skill level wear a pair of the Naboso Activation Insoles in their golf shoes and then play a round of golf. At the completion of the round, they were asked to complete a survey to find out their experience. 

This is what we found out.

Of the 50 golfers, 85% had never heard of or tried Naboso Insoles so this was a new experience and introduction to our textured product line.  This is good because it gives an honest response from a new customer. 

94% noticed increased foot awareness and pressure distribution during the round of golf. 

One golfer stated, "The insole texture provided constant stimulation which made me more aware of my feet and the terrain. They also decreased foot pain and pressure spots."

87% stated they noticed a benefit from the insoles which correlated to their golf game. 

This ranged from decreased foot and leg fatigue to improvement in their golf game.  This user stated, "Definitely shot one of my best round of the year, and I felt like I was more consistent with my shots. I think it was was the increased awareness of my feet."

98% stated they would wear them again and buy for their golf shoes 

This is of course one of our favorite questions because it says a lot if someone testing a product is wanting to re-purchase it and bring it as a normal feature in their golf game! 

Favourite Quotes from Golfers 

"I will be wearing them for every round I play in the future now." 

"They live in my golf shoes."

"Absolutely, everytime!"

"Yes, they are a fixture in my golf shoes."

***

We wanted to share this pilot study with you, our investors and those considering investing in Naboso as it shows the broad application of the Naboso product line in the performance market.  

To further support this growth we are carried by several golf pro shops and golf online resellers. 

Thank you so much. 

Dr Splichal, CEO 




Notice of Funds Disbursement

about 1 month ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, Naboso has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in Naboso be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

Naboso Neuropathy Pilot - Initial results are in!

about 2 months ago

Thank you all for your continued support in Naboso Technology, our mission and our crowd equity campaign! 


As you may know, research with our products is a very important part of our growth strategy.   To support this initial research we have initiated a Neuropathy Pilot Program using our Neuro Insoles. 


We are excited to share our initial findings below.   This is after 1 week of Neuro Insole use. 


40 subjects with varying types neuropathy 
Wore Neuro Insoles every day for 1 week
85% reported increase in foot awareness 
48% reported increase in balance and stability when walking.  


"I love them and have not taken them off"


"I'm so excited and impressed after wearing them for only 4 days!"


"I have neuropathy in the feet. The insoles have helped me to walk a little longer distance."


Stay tuned for full results!     Dr Splichal, CEO Naboso 


Notice of Funds Disbursement

2 months ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, Naboso has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in Naboso be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

Naboso Parkinson's Study - IRB Approved!

2 months ago

Thank you to all our investors and those following Naboso, considering to invest. 

We wanted to share the update that Hartford Healthcare just received IRB approval to conduct a randomized control trial to study Naboso Neuro Insoles with Parkinson's disease. 

This study will look at foot sensitivity and gait changes over a 30 day period when integrating Naboso Insoles vs.smooth insoles. 

***

This is just one of the many studies Naboso is initiating throughout 2021 with the end goal of increasing validation in the neuro rehab space and getting FDA Approval as a class 2 device for neuropathy. 

Your investment will play a pivotal role in this step! 

Thank you again, 

Dr Emily Splichal, CEO 

Over $90k raised in first 24 hours!

3 months ago

It is with strong moment that Naboso kicked off its first crowd equity campaign hitting an awesome investment milestone of over $90k in the first 24 hours.    


To all who have invested thus far we are very grateful for your support in Naboso's mission and vision to optimize movement from a sensory perspective.      


Stay tuned for continued updates during our investment journey and don't forget that movement is life, and life is sensory 


Dr Emily Splichal, CEO + Co-Founder 

Naboso 

Show More Updates End of Updates

Comments ({{profileCtrl.startup.comments_count}} total)

{{profileCtrl.newComment.body.length}}/2500
Please sign in to post a comment.
{{ profileCtrl.commentsLoading ? 'Loading...' : 'Show More Comments' }}